News
  • Qadir AK
    author-profile

    Qadir AK right arrow

    Author

    Qadir Ak is the founder of Coinpedia. He has over a decade of experience writing about technology and has been covering the blockchain and cryptocurrency space since 2010. He has also interviewed a few prominent experts within the cryptocurrency space.

    • author facebook
    • author twitter
    • linkedin

  • Updated by: Zameer Attar

    author image

    Zameer Attar right arrow

    Updated

    Zameer is a financial analyst and writer with a particular interest in cryptocurrency markets. He has been studying cryptocurrencies and their market behavior for several years and deeply understands the factors that affect the price of cryptocurrencies. His expertise lies in his ability to use both technical and fundamental analysis to make informed predictions about the future direction of cryptocurrency prices. He has a strong understanding of market sentiment and uses this to inform his trading decisions and price predictions.

    • Reviewed by: Zafar Naik

      author profile

      Zafar Naik right arrow

      Reviewed

      Zafar is a seasoned crypto and blockchain news writer with four years of experience. Known for accuracy, in-depth analysis, and a clear, engaging style, Zafar actively participates in blockchain communities. Beyond writing, Zafar enjoys trading and exploring the latest trends in the crypto market.

      • 2 minutes read

      Coinbase CEO Brian Armstrong Bags $130M for Longevity Startup NewLimit

      Story Highlights
      • Coinbase CEO Brian Armstrongโ€™s biotech startup NewLimit raised $130M to fight aging through cell reprogramming.

      • The Series B round values NewLimit at $810M, with backing from top investors like Kleiner Perkins and Founders Fund.

      • Armstrong is also pushing U.S. lawmakers to pass stablecoin legislation.

      While most crypto CEOs are busy navigating market volatility,Brian Armstrong is playing a far bigger game – taking on human aging and Washington regulations at the same time. Not exactly your typical founder story, right?ย 

      One moment heโ€™s rallying for stablecoin legislation on Capitol Hill, the next heโ€™s funding research to literally reverse the aging process.

      Hereโ€™s the latest on Armstrong, for all Coinbase enthusiasts out there! 

      NewLimit Raises $130M to Rewire Human Longevity

      Armstrongโ€™s biotech venture NewLimit, co-founded with former GV partner Blake Byers and stem cell scientist Jacob Kimmel, just closed a $130 million Series B round. The startup, now valued at $810 million, is developing therapies that aim to restore youthful function to aging cells through epigenetic reprogramming.

      Early results are promising. The team has identified three prototype medicines targeting liver cells – improving their fat and alcohol processing capabilities in lab tests. 

      While human trials are still years away, NewLimit is expanding into immune system research, with Armstrong citing the urgency of fighting what he calls the โ€œlargest source of human tragedyโ€ – aging.

      The round was led by Kleiner Perkins and backed by a powerful lineup of investors including Founders Fund, Elad Gil, Patrick Collison, and Garry Tan.

      Say No to Aging: Tech Titans Are All In!

      Armstrong isnโ€™t alone in this mission. He joins the ranks of tech elites like Jeff Bezos, Larry Ellison, and Vitalik Buterin – all pouring hundreds of millions into anti-aging research. But Armstrongโ€™s approach is distinctive: part-scientist, part-operator, and always ten steps ahead.

      Fighting for Stablecoin Regulations

      The Coinbase CEO hasnโ€™t loosened his grip on crypto advocacy. Just yesterday on X, he called on the U.S. Senate to move forward on the GENIUS Act – a stablecoin regulation bill that could finally bring clear rules to the space.

      The GENIUS Act would introduce a federal licensing regime, enforce reserve requirements for issuers, and create a dual regulatory model – splitting oversight between federal and state levels depending on issuer size. 

      The push comes just as the Treasury predicts stablecoins could surge from $230B to $2T by 2028, presenting both an opportunity and a risk to traditional banking systems.

      Never Miss a Beat in the Crypto World!

      Stay ahead with breaking news, expert analysis, and real-time updates on the latest trends in Bitcoin, altcoins, DeFi, NFTs, and more.

      Hereโ€™s how we see it: Brian Armstrong is betting on the future, and heโ€™s doing it from all sides.

      FAQs

      What is Brian Armstrong’s biotech company NewLimit?

      NewLimit is a biotech startup co-founded by Brian Armstrong to reverse aging via epigenetic cell reprogramming.

      What does the GENIUS Act mean for stablecoin regulation?

      The GENIUS Act proposes federal and state oversight, reserve rules, and licenses to regulate stablecoin issuers.

      Show More

      Related Articles

      Back to top button